Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.
They overcame the worst that life can throw at a kid - cancer and its debilitating surgeries, fatigue, vomiting and depression.
Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory...Show More Summary
Memorial Sloan Kettering Cancer Center launched the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
Three winners of the first-ever Breakthrough Prizes-- Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center; Cornelia I. Bargmann, PhD, of the Rockefeller University; and Lewis C. Cantley, PhD, of Weill Cornell Medical College...Show More Summary
We’ve been told that this has transpired in a matter of the last 24 hours, but yes, DigitasLBi has been appointed as agency partner for Memorial Sloan Kettering, the 130-year-old private cancer center based in NYC. We’ve been told that work for the center will be handled out of the New York and Boston DigitasLBi offices. Show More Summary
In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults. read more
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia...Show More Summary
NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to...Show More Summary
Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
IBM continues to expand the use of its Watson supercomputer from winning Jeopardy to handling incoming call-center questions to guiding cancer doctors at Memorial Sloan Kettering to better diagnoses. Today it announced a new pilot program for Watson at Houston’s renowned MD Anderson Cancer Center. The institution has been trying out Watson for a little [...]
IBM’s Watson will team up with Memorial Sloan Kettering this fall and plans to launch in a handful of cancer care centers this year, but Dan Cerutti, IBM’s GM of Watson Commercialization, said today at GigaOM Structure that Watson could be used in other fields too. [...]
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors...
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors. read more
Gustin L. Reichbach: This is not a law-and-order issue; it is a medical and a human rights issue. Being treated at Memorial Sloan Kettering Cancer Center, I am receiving the absolute gold standard of medical care. But doctors cannot be expected to do what the law prohibits, even when they know it is in the best interests of their patients. Show More Summary
For a computer, Watson gets some enviable gigs. Starting this week, ‘s Jeopardy-playing supercomputer is going to school at ‘s Memorial Sloan Kettering Cancer Center, where clinicians at the elite research hospital will begin “teaching” the computer to review oncological case histories and come up with the right treatments. The two organizations, and MSKCC, [...]
In the March 8 issue of the New England Journal of Medicine, a team of researchers at Memorial Sloan Kettering Cancer Center report on an extremely rare phenomenon known as the abscopal effect, in cancer patients with melanoma, treated with the immunotherapeutic agent ipilimumab (Yervoy™). Show More Summary
On March 27th, 2011, we learned the unthinkable: our 2 1/2 year old granddaughter, Emma Zinberg, had cancer. Within 24 hours, she was a patient at Memorial Sloan Kettering Cancer Center. While we had received an initial diagnosis of neuroblastoma at the hospital that found her tumor, the team of oncologists and surgeons at MSKCC [...]
Errant Gene Therapeutics, LLC ("EGT"), a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center ("MSKCC"). Show More Summary